Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
06/2006
06/13/2006USRE39132 Thiazoline acid derivatives
06/13/2006US7060827 Intermediates useful for making 2,4-pyrimidinediamine compounds
06/13/2006US7060721 Phosphodiesterase inhibitor; antidiabetic agents; atherosclerosis; cardiovascular disorders; polyctstic ovary syndrome; hypotensive agents; hyperglycemic agents
06/13/2006US7060711 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
06/13/2006US7060701 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis
06/13/2006CA2249562C Certain fused pyrrolecarboxamides as gaba brain receptor ligands
06/13/2006CA2238723C Arylethenesulfonamide derivatives and drug composition containing the same
06/08/2006WO2006060424A2 Inducible nitric oxide synthase dimerization inhibitors
06/08/2006WO2006060381A2 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library
06/08/2006WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof
06/08/2006WO2006058700A1 Acetamide compounds as fungicides
06/08/2006WO2006028972A3 Mercaptoamides as histone deacetylase inhibitors
06/08/2006WO2006010095A3 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
06/08/2006US20060123404 Computer program code size partitioning system and method for multiple memory multi-processing systems
06/08/2006US20060122397 Exhibiting an activity at metabotropic glutamate receptors (mGluRs), especially at the mGluR5 receptor; neurological disorders, psychiatric disorders, acute and chronic pain
06/08/2006US20060122386 Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulators
06/08/2006US20060122364 Process for producing dendrimer, building block compound, and process for producing thiophene compound
06/08/2006US20060122234 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
06/08/2006US20060122224 Quinoline and quinoxaline compounds
06/08/2006US20060122222 Heterocycle substituted carboxylic acids
06/08/2006US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis
06/08/2006US20060122195 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
06/08/2006US20060122188 Anticoagulants; 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-carboxypropyl]aminocarbonyl-4-(2-methylthiazol-4-yl)methoxyquinoline; antithrombotic agents in the treatment and prevention of thrombosis
06/08/2006US20060122181 Heteroaromatic pentacyclic compound and medicinal use thereof
06/08/2006US20060122166 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide
06/08/2006US20060122126 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity
06/08/2006US20060122063 5-methyl-2-(4-trifluoromethyl-1H-1-pyrazolyl)-4-(5-trifluoromethyl-3-thienyloxy)pyrimidine; broadleaf herbicide
06/08/2006CA2589770A1 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library
06/08/2006CA2589638A1 7-membered ring compound and method of production and pharmaceutical application thereof
06/08/2006CA2589433A1 Inducible nitric oxide synthase dimerization inhibitors
06/08/2006CA2589010A1 Biaryloxymethylarene carboxylic acids
06/08/2006CA2558647A1 Insecticidal n-substituted sulfoximines
06/07/2006EP1666469A1 Plasminogen activator inhibitor-1 inhibitor
06/07/2006EP1666464A1 Piperidine derivative having nmda receptor antagonistic activity
06/07/2006EP1666462A1 N-[1h-indol-5-yl]naphthalene-1-sulphonamide derivatives and related compounds as serotonin 5-ht6 receptor antagonists for the treatment of disorders of the central nervous system
06/07/2006EP1666455A1 Amide type carboxamide derivative
06/07/2006EP1666067A1 Drug containing chymase inhibitor as the active ingredient
06/07/2006EP1664092A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease
06/07/2006EP1664037A1 Halo substituted benzo [b] thiophenes with pi3k inhibitory activity as therapeutic agents
06/07/2006EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors
06/07/2006EP1664025A1 Pyrrol derivatives with antibacterial activity
06/07/2006EP1664023A1 Sustituted isoquinoline derivatives and methods of use
06/07/2006EP1664021A1 N-substituted benzimidazolyl c-kit inhibitors
06/07/2006EP1664018A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5
06/07/2006EP1664015A1 Substituted naphthyl benzothiophene acids
06/07/2006EP1664013A1 Calcilytic compounds
06/07/2006EP1664010A1 Sulfonamides antagonising n-type calcium channels
06/07/2006EP1664004A1 Method for the production of 4-(4-aminophenyl)-3-morpholinon
06/07/2006EP1663982A1 Aminoquinoline derivatives and their use as adenosine a3 ligands
06/07/2006EP1663976A1 4-pyridinylmethyl sulfonamide derivatives as fungicidal plant protection agents
06/07/2006EP1663975A1 Novel gamma secretase inhibitors
06/07/2006EP1663973A1 2-pyridone derivatives as neutrophil elastase inhibitors and their use
06/07/2006EP1663971A1 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
06/07/2006EP1663959A1 Novel amidine compounds for treating microbial infections
06/07/2006EP1663953A1 Inhibitors of histone deacetylase
06/07/2006EP1663254A2 Anti-inflamatory phosphonate conjugates
06/07/2006EP1663248A1 7-heteroarylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
06/07/2006EP1663241A1 5-arylpyrimidines as anticancer agents
06/07/2006EP1663237A2 Fused ring heterocycles as potassium channel modulators
06/07/2006EP1663204A2 C-kit modulators and methods of use
06/07/2006EP1663202A1 Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
06/07/2006EP1663184A2 Hydantoin derivatives as inhibitors of cellular necrosis
06/07/2006EP1448577B1 Rhodium and iridium complexes
06/07/2006EP1355889B1 Substituted triazole diamine derivatives as kinase inhibitors
06/07/2006EP1309559B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
06/07/2006EP1056725B1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas
06/07/2006CN1784416A 9-ketospinosyn derivatives
06/07/2006CN1784399A 3-carbonylaminothiophenes and their use as fungicides
06/07/2006CN1784393A Chemical compounds
06/07/2006CN1783010A Program code size partitioning system and method for multiple memory multi-processing systems
06/07/2006CN1258529C Process for preparing diaryl-4-amino-piperidinyl compounds
06/06/2006US7057076 which have improved receptor binding affinity via substituted alkyl side chains at the c-3 position; may contain terpene funtionality combined with resorcinol moieties; for treatment of nervous system disorders and cardiovascular disorders
06/06/2006US7057054 Hexafluorocyclopentene di-substituted with an alkoxy- and aryl-substituted furan and/or thiophene; e.g., 1,2-bis(2-methoxy-5-phenyl-3-thienyl)hexafluorocyclopentene; nonfading
06/06/2006US7057048 Androgen receptor antagonists
06/06/2006US7057035 reacting aryl/heteroaryl triflate/halide with carbon monoxide and N-hydroxysuccinimide in solvent in presence of palladium catalyst and base
06/06/2006US7056946 antitumor taxane containing a carboante group at c-10 position, benzoyoxy at c-2 position and hydroxy at c-7 position in the ring (c3o-c6-c6-c8)
06/06/2006US7056940 effective in controlling lepidoptera, coleoptera, mites and other sucking pests
06/06/2006US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists
06/06/2006US7056935 Administering to the animal suffering from neurological disorders an amide compound having an affinity for FKBP-type immunophilins
06/06/2006US7056926 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis
06/06/2006US7056923 Anticoagulants
06/06/2006US7056918 Benzimidazole anti-inflammatory compounds
06/06/2006US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists
06/06/2006US7056354 produces powerful, particularly bright and chromatic color, particularly red shades that are free of or contain very little blue or yellow; resistance to light, bad weather, washing, permanent-waving, perspiration and friction
06/06/2006US7056348 Comprises mixing 5-(2,4-dimethoxyphenyl)-1,3,3-trimethyl-2-methylene-indoline and carbonyl compound (4-hydroxy-3-methoxy-benzaldehyde) for dyeing keratin fibers (wool, silk, and/or hair)
06/06/2006CA2213810C Benzo¬b|thiophene compounds, intermediates, processes, compositions and methods
06/06/2006CA2166800C 4-substituted piperidine derivatives useful as neurokinin antagonists
06/06/2006CA2163601C 2-aminobenzenesulfonic acid and 2-aminobenzenesulfonyle chloride derivatives
06/06/2006CA2158973C 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity
06/01/2006WO2006058012A2 Gonadotropin releasing hormone receptor antagonists
06/01/2006WO2006057961A1 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
06/01/2006WO2006057868A1 Antithrombotic diamides
06/01/2006WO2006057845A1 Aromatic ether derivatives useful as thrombin inhibitors
06/01/2006WO2006036015A3 6- (pyridinyl) -4-pyrimidone derivates as tau protein kinase 1 inhibitors
06/01/2006WO2005118537A3 Arylpiperazine derivatives as adrenergic receptor antagonists
06/01/2006WO2005061467A3 Piperazine derivatives as bradykinin antagonists
06/01/2006US20060116421 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; antiinflammatory agent; antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis
06/01/2006US20060116408 Chymase inhibitor; cardiovascular disorders, circulation diseases; hypotensive agents; methyl 4-(5-chloro-3-methylbenzo[b]thiophene-2-sulfonylamino)-3-methanesulfonylbenzoate
06/01/2006US20060116402 N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole library
06/01/2006US20060116399 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof